Literature DB >> 15746534

Transglutaminases in neurodegenerative disorders.

Craig D C Bailey1, Janusz Tucholski, Gail V W Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746534     DOI: 10.1159/000084238

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN: 0079-6263


× No keyword cloud information.
  9 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.

Authors:  Hyoungseok Ju; Hiroshi Kokubu; Janghoo Lim
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.

Authors:  D R D'Souza; J Wei; Q Shao; M D Hebert; S H Subramony; P J S Vig
Journal:  Neurosci Lett       Date:  2006-10-11       Impact factor: 3.046

4.  Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.

Authors:  Cornelius Klöck; Xi Jin; Kihang Choi; Chaitan Khosla; Peter B Madrid; Andrew Spencer; Brian C Raimundo; Paul Boardman; Guido Lanza; John H Griffin
Journal:  Bioorg Med Chem Lett       Date:  2010-12-16       Impact factor: 2.823

5.  Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules.

Authors:  Yuyu Song; Laura L Kirkpatrick; Alexander B Schilling; Donald L Helseth; Nicolas Chabot; Jeffrey W Keillor; Gail V W Johnson; Scott T Brady
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

6.  Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1.

Authors:  P J S Vig; J Wei; Q Shao; M D Hebert; S H Subramony; L T Sutton
Journal:  Neurosci Lett       Date:  2007-04-05       Impact factor: 3.046

Review 7.  Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.

Authors:  Benedict Onyekachi Odii; Peter Coussons
Journal:  ScientificWorldJournal       Date:  2014-03-23

8.  Comparative Profiling of TG2 and Its Effectors in Human Relapsing Remitting and Progressive Multiple Sclerosis.

Authors:  Damien D Pearse; Andrew B Hefley; Alejo A Morales; Mousumi Ghosh
Journal:  Biomedicines       Date:  2022-05-26

9.  Genome-wide search reveals the existence of a limited number of thyroid hormone receptor alpha target genes in cerebellar neurons.

Authors:  Fabrice Chatonnet; Romain Guyot; Frédéric Picou; Maria Bondesson; Frederic Flamant
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.